Dear reader,
January 2026…
One small gold stock just started to mine its first ounce of gold.
I believe that once this news hits the markets, it will send this $2 gold stock soaring.
That’s because right now, the company is pre-revenue.
So, it’s invisible to the algos and AI programs that make up the bulk of daily trading.
But now it started to generate gold - and cash - it will be like flicking a light switch once the Wall Street Automated Trading Systems(ATS) can see the numbers.
The world’s most powerful trading computers will bid up prices to match fair value.
And it all happens when the company’s first financial reports are posted in May 2026.
Which means:
You need to own this company now - before the company’s initial production is made public.
Click here to get the full briefing before it’s too late.
Best,
Garrett Goggin, CFA, CMT
Lead Analyst and Founder, Golden Portfolio
These 3 Cash Flow Machines Provide Stability in Uncertain Markets
Author: Nathan Reiff. Published: 3/6/2026.
Key Points
- Cash flow generation is a key attribute of stable companies, allowing them flexibility to not only maintain operations but also to grow and to return value to shareholders via dividends or buybacks.
- Gilead Sciences and AbbVie are two large biopharma firms with a compelling history of cash flow generation, helping to facilitate continued R&D and pipeline development, among other things.
- Visa converts about half or more of its revenue to free cash flow, capitalizing on its high-margin business to facilitate growth and dividend payments.
- Special Report: The Biggest IPO Ever: Claim Your Stake Today
When times get tough, cash flow can determine a company's viability through a challenging market. If a firm cannot meet near-term obligations with cash on hand, it risks collapsing. Equally important, cash flow enables longer-term planning—everything from expansion and acquisitions to strategic returns of shareholder value depends on it.
While it's just one of many measures of a stock's stability, cash flow may be especially important for investors seeking companies likely to remain steady amid broad market uncertainty in 2026. The three companies below are household names and major industry players with strong cash-flow track records that support their plans for continued growth.
Strong Free Cash Flow Yield and Commitment to Returning Value to Investors
Elon Musk's $1 Quadrillion AI IPO (Ad)
Elon Musk's $1 Quadrillion AI IPO
$1 quadrillion would be enough to send a check for $2.8 million to every man, woman, and child in America.
That's how big this opportunity is.
This is set to be the biggest AI IPO in history…
And you could claim a stake today…
Before the company goes public…
Starting with just $500.
Anchored by top-selling drugs for COVID-19, HIV, certain cancers and more, Gilead Sciences Inc. (NASDAQ: GILD) is among the largest biopharma firms available to investors. The company offers a compelling level of free cash flow relative to its share price—its free cash flow yield is roughly 6%.
Even better for investors, the firm is committed to returning at least half of its free cash flow each year to stockholders. In 2025, including its dividend distributions, Gilead returned 63% of its annual free cash flow to shareholders.
Despite its large size and established position, Gilead has continued to grow. In Q4 2025 it beat analyst expectations for both earnings per share and revenue, supported by legacy products and a healthy pipeline. In 2026, the company anticipates at least four major commercial rollouts of new products, helping to maintain a diversified portfolio.
To be sure, Gilead faces strong competition in biopharma—particularly in oncology, an area some investors want to see contribute more to total sales. Nonetheless, a large majority of Wall Street analysts have bullish ratings on GILD shares and see roughly 6% additional upside potential even after the stock has risen more than 28% over the past year.
Massive Dividend Growth Made Possible By Solid Cash Generation Power
Another major biopharma name, AbbVie (NYSE: ABBV), posts a free cash flow yield above 5%, strong for a company of its scale. While it sells therapeutics across many medical areas, one of AbbVie's most compelling attributes for investors is its dividend.
AbbVie currently has a dividend yield that sits around 2.9% and has more than quadrupled its dividend distributions since becoming a public company over a decade ago.
Although the company reports a high dividend payout ratio (293%), which might concern some investors about the sustainability of payouts, that ratio is supported by very strong free cash flow. In 2025, for example, AbbVie generated nearly $18 billion in free cash flow while paying out about $11.7 billion in total dividends.
The firm has continued to grow earnings and revenue, beating Wall Street expectations in Q4 2025 and guiding higher. Growth has been driven by two leading drugs, Skyrizi and Rinvoq, and AbbVie continues to invest heavily in R&D to deepen its pipeline.
Excellent Cash Generation Capacity Amid Consumer Resilience
Payments giant Visa Inc. (NYSE: V) operates a high-margin business model that generates substantial free cash flow, often converting half or more of revenue into free cash flow in many quarters. With strong revenue performance—a 14.6% year-over-year improvement in the most recent period, for instance—Visa is a reliable cash machine for many investors.
Despite macro concerns such as tariffs and inflation, Visa's payments volume and processed transactions continue to rise, and consumer spending has shown resilience. That performance has allowed Visa to keep raising its dividend; it currently offers a yield of 0.83% with a manageable 25.1% payout ratio. It's no surprise that analysts view Visa as a solid Buy, with roughly 22% upside potential expected going forward.
Defense Stocks: Rockets, Radars, and Record Backlogs
Reported by Jeffrey Neal Johnson. First Published: 3/3/2026.
Key Points
- The recent market rally reflects a deeper investor understanding of the defense sector’s foundational financial strength and strategic importance.
- Extensive multi-year order backlogs provide these companies with exceptional revenue visibility and insulate them from typical market volatility.
- Leadership in producing critical next-generation military technologies positions these defense giants for a long-term cycle of elevated global demand.
- Special Report: The Biggest IPO Ever: Claim Your Stake Today
In response to escalating geopolitical tensions in the Middle East, the defense sector has seized the market's attention.
Shares of industry leaders Lockheed Martin (NYSE: LMT), RTX Corporation (NYSE: RTX), and Northrop Grumman (NYSE: NOC) have surged, with several hitting new highs on substantially higher trading volume.
Elon Musk's $1 Quadrillion AI IPO (Ad)
Elon Musk's $1 Quadrillion AI IPO
$1 quadrillion would be enough to send a check for $2.8 million to every man, woman, and child in America.
That's how big this opportunity is.
This is set to be the biggest AI IPO in history…
And you could claim a stake today…
Before the company goes public…
Starting with just $500.
This sharp run-up has raised a key question among investors: Is the rally a temporary, fear-driven spike, or does it reflect a more durable recognition of the sector's fundamentals? A closer look at these companies' financial positions suggests the latter: the strength was in place well before the current crisis, and the market may simply be catching up to a deeper reality.
Why This Time Is Different
Recent military actions involving the U.S. and its allies have acted as a powerful catalyst, shifting the market's view of the defense industry. The immediate effect is an expectation of higher global military spending. This is not merely a short-term reaction to replenish expended munitions; it signals a broader strategic realignment.
Nations are reassessing long-term defense postures in a world seen as more volatile, accelerating modernization programs and increasing investment in next-generation technology.
The character of modern conflict — with its emphasis on precision missiles, advanced air-defense systems, and sophisticated surveillance networks — creates sustained demand for the core products these defense giants supply. Recent events have highlighted systems such as the Patriot missile battery, the F-35 combat jet, and strategic bombers. For companies that produce these assets, the geopolitical environment underscores their essential role in national and global security, prompting a broad re-evaluation of their long-term growth prospects and intrinsic value.
The Bedrock of Long-Term Value
While recent events provided the spark, the sector's rally is grounded in a pre-existing base of financial strength. The most telling indicator is the companies' order backlogs — the total value of signed and awarded contracts for future work.
These backlogs, totaling hundreds of billions of dollars, represent years of secured revenue and give investors a clearer view of future business activity. They insulate these firms from commercial-market volatility and form the foundation of the bull case.
A closer look at order books shows a multi-year runway for growth, anchored by programs considered essential to national security.
- RTX Corporation (RTX) holds a backlog of roughly $268 billion. This sizable figure continues to grow, supported by multi-year agreements to boost production of its Tomahawk and AMRAAM missile systems. With a trailing price-to-earnings ratio (P/E) near 42.68 and a dividend yield of 1.28%, RTX blends growth potential with shareholder returns. Its Raytheon segment is a global leader in advanced sensor and missile technologies — now a top priority for defense ministries worldwide — positioning the company to capture a large share of new spending.
- Lockheed Martin (LMT), with a backlog of about $194 billion, demonstrates considerable stability. Much of this future revenue is tied to long-lived programs like the F-35 fighter jet, which provides multi-decade streams from production, software upgrades, and sustainment. Lockheed's Missiles and Fire Control division, which produces PAC-3 and THAAD interceptors, reported robust 14% revenue growth in its last reported quarter, indicating strong demand that predates the current crisis.
- Northrop Grumman (NOC) has a backlog exceeding $95.7 billion, driven by leadership in high-tech strategic platforms. Central to this is the B-21 Raider stealth bomber, a next-generation system that is a priority for U.S. defense strategy. A recent agreement to accelerate B-21 production highlights sustained government commitment. With a P/E around 25.95 and consistent dividend payments, Northrop displays financial discipline while its role in space and unmanned systems positions it for long-term relevance.
Redefined and Ready for Growth
The recent jump in defense stock valuations looks to be more than a fleeting reaction to conflict. It reflects a repricing based on a new assessment of global risk and sustained, non-cyclical demand. The geopolitical crisis was the catalyst, but the rally is backed by record backlogs and multi-decade strategic programs.
That operational strength is reinforced by solid financial health, shown by steady revenue growth and reliable dividend payments that appeal to long-term investors. The market appears to be establishing a higher valuation floor for the sector, recognizing these companies' unique positioning for a prolonged period of elevated demand. Going forward, focus will shift to how effectively these defense leaders convert historic backlogs into accelerating earnings and cash flow as they execute ambitious production schedules.
This email message is a sponsored message from Golden Portfolio, a third-party advertiser of MarketBeat. Why was I sent this email content?.
If you need help with your newsletter, feel free to email MarketBeat's U.S. based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 North Reid Place, Suite 620, Sioux Falls, South Dakota 57103. USA..